Industry Research Reports
Home > Reports > Chemical & Material > Global Melatonin API Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Melatonin API Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Chemical & Material
Published Date: 2025-10-03
Pages: 177 Pages
Report ld: 5108336
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Melatonin API Market Size(US$)
CAGR 2025-2031
8.2%
Market Size,2031
USD 182
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 114 million
Market Forecast in 2031(Value)
US$ 182 million
CAGR
8.2%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Melatonin API market is projected to grow from US$ 106 million in 2024 to US$ 182 million by 2031, at a CAGR of 8.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
The term "API" in the context of pharmaceuticals stands for Active Pharmaceutical Ingredient. An Active Pharmaceutical Ingredient is the biologically active component of a drug, and it is responsible for its therapeutic effects. Melatonin is a hormone naturally produced in the pineal gland of the brain, and it plays a crucial role in regulating the sleep-wake cycle. When used in the context of pharmaceuticals, "Melatonin API" refers to the active pharmaceutical ingredient of melatonin that is isolated and used as the primary therapeutic agent in medications.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Melatonin API market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Merck KGaA
- Caesar & Loretz GmbH
- EVONIK
- Bio-Techne Corp.
- Cayman Chemical Company (Matreya)
- Spectrum Chemical
- Caesar & Loretz GmbH
- LGM Pharma
- Flavine Europe GmbH
- Ralington Pharma
- SimSon Pharma Limited
- Santa Cruz Biotechnology, Inc.
- Biosynth
- Otto Chemie Pvt. Ltd.
- Pharmaffiliates Analytics and Synthetics P. Ltd.
- Clearsynth Labs
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Natural
- Synthetic
Segment by Application
- Biotechnology Company
- Pharmaceutical Company
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Melatonin API study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Melatonin API: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Melatonin API Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Natural
1.2.3 Synthetic
1.3 Market Segmentation by Application
1.3.1 Global Melatonin API Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Biotechnology Company
1.3.3 Pharmaceutical Company
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Melatonin API Revenue Estimates and Forecasts 2020-2031
2.2 Global Melatonin API Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Melatonin API Sales Estimates and Forecasts 2020-2031
2.4 Global Melatonin API Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global Melatonin API Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan
4 Competition by Manufacturers
4.1 Global Melatonin API Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Melatonin API Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 Natural Market Size by Manufacturers
4.5.2 Synthetic Market Size by Manufacturers
4.6 Global Melatonin API Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global Melatonin API Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global Melatonin API Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global Melatonin API Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Melatonin API Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Melatonin API Sales and Revenue by Type (2020-2031)
7.4 North America Melatonin API Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Melatonin API Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Melatonin API Sales and Revenue by Type (2020-2031)
8.4 Europe Melatonin API Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Melatonin API Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Melatonin API Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific Melatonin API Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Melatonin API Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Melatonin API Sales and Revenue by Type (2020-2031)
10.4 Central and South America Melatonin API Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Melatonin API Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Melatonin API Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa Melatonin API Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Melatonin API Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 Merck KGaA
12.1.1 Merck KGaA Corporation Information
12.1.2 Merck KGaA Business Overview
12.1.3 Merck KGaA Melatonin API Product Models, Descriptions and Specifications
12.1.4 Merck KGaA Melatonin API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 Merck KGaA Melatonin API Sales by Product in 2024
12.1.6 Merck KGaA Melatonin API Sales by Application in 2024
12.1.7 Merck KGaA Melatonin API Sales by Geographic Area in 2024
12.1.8 Merck KGaA Melatonin API SWOT Analysis
12.1.9 Merck KGaA Recent Developments
12.2 Caesar & Loretz GmbH
12.2.1 Caesar & Loretz GmbH Corporation Information
12.2.2 Caesar & Loretz GmbH Business Overview
12.2.3 Caesar & Loretz GmbH Melatonin API Product Models, Descriptions and Specifications
12.2.4 Caesar & Loretz GmbH Melatonin API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 Caesar & Loretz GmbH Melatonin API Sales by Product in 2024
12.2.6 Caesar & Loretz GmbH Melatonin API Sales by Application in 2024
12.2.7 Caesar & Loretz GmbH Melatonin API Sales by Geographic Area in 2024
12.2.8 Caesar & Loretz GmbH Melatonin API SWOT Analysis
12.2.9 Caesar & Loretz GmbH Recent Developments
12.3 EVONIK
12.3.1 EVONIK Corporation Information
12.3.2 EVONIK Business Overview
12.3.3 EVONIK Melatonin API Product Models, Descriptions and Specifications
12.3.4 EVONIK Melatonin API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 EVONIK Melatonin API Sales by Product in 2024
12.3.6 EVONIK Melatonin API Sales by Application in 2024
12.3.7 EVONIK Melatonin API Sales by Geographic Area in 2024
12.3.8 EVONIK Melatonin API SWOT Analysis
12.3.9 EVONIK Recent Developments
12.4 Bio-Techne Corp.
12.4.1 Bio-Techne Corp. Corporation Information
12.4.2 Bio-Techne Corp. Business Overview
12.4.3 Bio-Techne Corp. Melatonin API Product Models, Descriptions and Specifications
12.4.4 Bio-Techne Corp. Melatonin API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 Bio-Techne Corp. Melatonin API Sales by Product in 2024
12.4.6 Bio-Techne Corp. Melatonin API Sales by Application in 2024
12.4.7 Bio-Techne Corp. Melatonin API Sales by Geographic Area in 2024
12.4.8 Bio-Techne Corp. Melatonin API SWOT Analysis
12.4.9 Bio-Techne Corp. Recent Developments
12.5 Cayman Chemical Company (Matreya)
12.5.1 Cayman Chemical Company (Matreya) Corporation Information
12.5.2 Cayman Chemical Company (Matreya) Business Overview
12.5.3 Cayman Chemical Company (Matreya) Melatonin API Product Models, Descriptions and Specifications
12.5.4 Cayman Chemical Company (Matreya) Melatonin API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 Cayman Chemical Company (Matreya) Melatonin API Sales by Product in 2024
12.5.6 Cayman Chemical Company (Matreya) Melatonin API Sales by Application in 2024
12.5.7 Cayman Chemical Company (Matreya) Melatonin API Sales by Geographic Area in 2024
12.5.8 Cayman Chemical Company (Matreya) Melatonin API SWOT Analysis
12.5.9 Cayman Chemical Company (Matreya) Recent Developments
12.6 Spectrum Chemical
12.6.1 Spectrum Chemical Corporation Information
12.6.2 Spectrum Chemical Business Overview
12.6.3 Spectrum Chemical Melatonin API Product Models, Descriptions and Specifications
12.6.4 Spectrum Chemical Melatonin API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 Spectrum Chemical Recent Developments
12.7 Caesar & Loretz GmbH
12.7.1 Caesar & Loretz GmbH Corporation Information
12.7.2 Caesar & Loretz GmbH Business Overview
12.7.3 Caesar & Loretz GmbH Melatonin API Product Models, Descriptions and Specifications
12.7.4 Caesar & Loretz GmbH Melatonin API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.5 Caesar & Loretz GmbH Recent Developments
12.8 LGM Pharma
12.8.1 LGM Pharma Corporation Information
12.8.2 LGM Pharma Business Overview
12.8.3 LGM Pharma Melatonin API Product Models, Descriptions and Specifications
12.8.4 LGM Pharma Melatonin API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.8.5 LGM Pharma Recent Developments
12.9 Flavine Europe GmbH
12.9.1 Flavine Europe GmbH Corporation Information
12.9.2 Flavine Europe GmbH Business Overview
12.9.3 Flavine Europe GmbH Melatonin API Product Models, Descriptions and Specifications
12.9.4 Flavine Europe GmbH Melatonin API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.9.5 Flavine Europe GmbH Recent Developments
12.10 Ralington Pharma
12.10.1 Ralington Pharma Corporation Information
12.10.2 Ralington Pharma Business Overview
12.10.3 Ralington Pharma Melatonin API Product Models, Descriptions and Specifications
12.10.4 Ralington Pharma Melatonin API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.10.5 Ralington Pharma Recent Developments
12.11 SimSon Pharma Limited
12.11.1 SimSon Pharma Limited Corporation Information
12.11.2 SimSon Pharma Limited Business Overview
12.11.3 SimSon Pharma Limited Melatonin API Product Models, Descriptions and Specifications
12.11.4 SimSon Pharma Limited Melatonin API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.11.5 SimSon Pharma Limited Recent Developments
12.12 Santa Cruz Biotechnology, Inc.
12.12.1 Santa Cruz Biotechnology, Inc. Corporation Information
12.12.2 Santa Cruz Biotechnology, Inc. Business Overview
12.12.3 Santa Cruz Biotechnology, Inc. Melatonin API Product Models, Descriptions and Specifications
12.12.4 Santa Cruz Biotechnology, Inc. Melatonin API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.12.5 Santa Cruz Biotechnology, Inc. Recent Developments
12.13 Biosynth
12.13.1 Biosynth Corporation Information
12.13.2 Biosynth Business Overview
12.13.3 Biosynth Melatonin API Product Models, Descriptions and Specifications
12.13.4 Biosynth Melatonin API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.13.5 Biosynth Recent Developments
12.14 Otto Chemie Pvt. Ltd.
12.14.1 Otto Chemie Pvt. Ltd. Corporation Information
12.14.2 Otto Chemie Pvt. Ltd. Business Overview
12.14.3 Otto Chemie Pvt. Ltd. Melatonin API Product Models, Descriptions and Specifications
12.14.4 Otto Chemie Pvt. Ltd. Melatonin API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.14.5 Otto Chemie Pvt. Ltd. Recent Developments
12.15 Pharmaffiliates Analytics and Synthetics P. Ltd.
12.15.1 Pharmaffiliates Analytics and Synthetics P. Ltd. Corporation Information
12.15.2 Pharmaffiliates Analytics and Synthetics P. Ltd. Business Overview
12.15.3 Pharmaffiliates Analytics and Synthetics P. Ltd. Melatonin API Product Models, Descriptions and Specifications
12.15.4 Pharmaffiliates Analytics and Synthetics P. Ltd. Melatonin API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.15.5 Pharmaffiliates Analytics and Synthetics P. Ltd. Recent Developments
12.16 Clearsynth Labs
12.16.1 Clearsynth Labs Corporation Information
12.16.2 Clearsynth Labs Business Overview
12.16.3 Clearsynth Labs Melatonin API Product Models, Descriptions and Specifications
12.16.4 Clearsynth Labs Melatonin API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.16.5 Clearsynth Labs Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Melatonin API Industry Chain
13.2 Melatonin API Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Melatonin API Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Melatonin API Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Melatonin API Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global Melatonin API Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Melatonin API Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Melatonin API Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Melatonin API Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Melatonin API Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Melatonin API Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Melatonin API Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
Table 7. Global Melatonin API Sales by Region (2020-2025) & (Tons)
Table 8. Global Melatonin API Sales by Region (2026-2031) & (Tons)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Melatonin API Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
Table 11. Global Melatonin API Production by Region (2020-2025) & (Tons)
Table 12. Global Melatonin API Production by Region (2026-2031) & (Tons)
Table 13. Global Melatonin API Sales by Manufacturers (2020-2025) & (Tons)
Table 14. Global Melatonin API Sales Share by Manufacturers (2020-2025)
Table 15. Global Melatonin API Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 16. Global Melatonin API Revenue Market Share by Manufacturers (2020-2025)
Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 18. Global Melatonin API by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Melatonin API as of 2024)
Table 19. Global Melatonin API Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 20. Global Melatonin API Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Ton)
Table 21. Key Manufacturers Melatonin API Manufacturing Base and Headquarters
Table 22. Global Melatonin API Market Concentration Ratio (CR5 and HHI)
Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 25. Global Melatonin API Sales by Type (2020-2025) & (Tons)
Table 26. Global Melatonin API Sales by Type (2026-2031) & (Tons)
Table 27. Global Melatonin API Revenue by Type (2020-2025) & (US$ Million)
Table 28. Global Melatonin API Revenue by Type (2026-2031) & (US$ Million)
Table 29. Global Melatonin API ASP by Type (2020-2031) & (US$/Ton)
Table 30. Technical Specifications by Key Product Type
Table 31. Global Melatonin API Sales by Application (2020-2025) & (Tons)
Table 32. Global Melatonin API Sales by Application (2026-2031) & (Tons)
Table 33. Melatonin API High-Growth Sectors Demand CAGR (2024-2031)
Table 34. Global Melatonin API Revenue by Application (2020-2025) & (US$ Million)
Table 35. Global Melatonin API Revenue by Application (2026-2031) & (US$ Million)
Table 36. Global Melatonin API ASP by Application (2020-2031) & (US$/Ton)
Table 37. Top Customers by Region
Table 38. Top Customers by Application
Table 39. North America Melatonin API Growth Accelerators and Market Barriers
Table 40. North America Melatonin API Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 41. North America Melatonin API Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 42. Europe Melatonin API Growth Accelerators and Market Barriers
Table 43. Europe Melatonin API Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 44. Europe Melatonin API Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 45. Asia-Pacific Melatonin API Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Asia-Pacific Melatonin API Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 47. Asia-Pacific Melatonin API Growth Accelerators and Market Barriers
Table 48. Southeast Asia Melatonin API Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 49. Central and South America Melatonin API Investment Opportunities and Key Challenges
Table 50. Central and South America Melatonin API Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 51. Middle East and Africa Melatonin API Investment Opportunities and Key Challenges
Table 52. Middle East and Africa Melatonin API Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 53. Merck KGaA Corporation Information
Table 54. Merck KGaA Description and Major Businesses
Table 55. Merck KGaA Product Models, Descriptions and Specifications
Table 56. Merck KGaA Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 57. Merck KGaA Sales Value Proportion by Product in 2024
Table 58. Merck KGaA Sales Value Proportion by Application in 2024
Table 59. Merck KGaA Sales Value Proportion by Geographic Area in 2024
Table 60. Merck KGaA Melatonin API SWOT Analysis
Table 61. Merck KGaA Recent Developments
Table 62. Caesar & Loretz GmbH Corporation Information
Table 63. Caesar & Loretz GmbH Description and Major Businesses
Table 64. Caesar & Loretz GmbH Product Models, Descriptions and Specifications
Table 65. Caesar & Loretz GmbH Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 66. Caesar & Loretz GmbH Sales Value Proportion by Product in 2024
Table 67. Caesar & Loretz GmbH Sales Value Proportion by Application in 2024
Table 68. Caesar & Loretz GmbH Sales Value Proportion by Geographic Area in 2024
Table 69. Caesar & Loretz GmbH Melatonin API SWOT Analysis
Table 70. Caesar & Loretz GmbH Recent Developments
Table 71. EVONIK Corporation Information
Table 72. EVONIK Description and Major Businesses
Table 73. EVONIK Product Models, Descriptions and Specifications
Table 74. EVONIK Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 75. EVONIK Sales Value Proportion by Product in 2024
Table 76. EVONIK Sales Value Proportion by Application in 2024
Table 77. EVONIK Sales Value Proportion by Geographic Area in 2024
Table 78. EVONIK Melatonin API SWOT Analysis
Table 79. EVONIK Recent Developments
Table 80. Bio-Techne Corp. Corporation Information
Table 81. Bio-Techne Corp. Description and Major Businesses
Table 82. Bio-Techne Corp. Product Models, Descriptions and Specifications
Table 83. Bio-Techne Corp. Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 84. Bio-Techne Corp. Sales Value Proportion by Product in 2024
Table 85. Bio-Techne Corp. Sales Value Proportion by Application in 2024
Table 86. Bio-Techne Corp. Sales Value Proportion by Geographic Area in 2024
Table 87. Bio-Techne Corp. Melatonin API SWOT Analysis
Table 88. Bio-Techne Corp. Recent Developments
Table 89. Cayman Chemical Company (Matreya) Corporation Information
Table 90. Cayman Chemical Company (Matreya) Description and Major Businesses
Table 91. Cayman Chemical Company (Matreya) Product Models, Descriptions and Specifications
Table 92. Cayman Chemical Company (Matreya) Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 93. Cayman Chemical Company (Matreya) Sales Value Proportion by Product in 2024
Table 94. Cayman Chemical Company (Matreya) Sales Value Proportion by Application in 2024
Table 95. Cayman Chemical Company (Matreya) Sales Value Proportion by Geographic Area in 2024
Table 96. Cayman Chemical Company (Matreya) Melatonin API SWOT Analysis
Table 97. Cayman Chemical Company (Matreya) Recent Developments
Table 98. Spectrum Chemical Corporation Information
Table 99. Spectrum Chemical Description and Major Businesses
Table 100. Spectrum Chemical Product Models, Descriptions and Specifications
Table 101. Spectrum Chemical Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 102. Spectrum Chemical Recent Developments
Table 103. Caesar & Loretz GmbH Corporation Information
Table 104. Caesar & Loretz GmbH Description and Major Businesses
Table 105. Caesar & Loretz GmbH Product Models, Descriptions and Specifications
Table 106. Caesar & Loretz GmbH Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 107. Caesar & Loretz GmbH Recent Developments
Table 108. LGM Pharma Corporation Information
Table 109. LGM Pharma Description and Major Businesses
Table 110. LGM Pharma Product Models, Descriptions and Specifications
Table 111. LGM Pharma Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 112. LGM Pharma Recent Developments
Table 113. Flavine Europe GmbH Corporation Information
Table 114. Flavine Europe GmbH Description and Major Businesses
Table 115. Flavine Europe GmbH Product Models, Descriptions and Specifications
Table 116. Flavine Europe GmbH Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 117. Flavine Europe GmbH Recent Developments
Table 118. Ralington Pharma Corporation Information
Table 119. Ralington Pharma Description and Major Businesses
Table 120. Ralington Pharma Product Models, Descriptions and Specifications
Table 121. Ralington Pharma Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 122. Ralington Pharma Recent Developments
Table 123. SimSon Pharma Limited Corporation Information
Table 124. SimSon Pharma Limited Description and Major Businesses
Table 125. SimSon Pharma Limited Product Models, Descriptions and Specifications
Table 126. SimSon Pharma Limited Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 127. SimSon Pharma Limited Recent Developments
Table 128. Santa Cruz Biotechnology, Inc. Corporation Information
Table 129. Santa Cruz Biotechnology, Inc. Description and Major Businesses
Table 130. Santa Cruz Biotechnology, Inc. Product Models, Descriptions and Specifications
Table 131. Santa Cruz Biotechnology, Inc. Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 132. Santa Cruz Biotechnology, Inc. Recent Developments
Table 133. Biosynth Corporation Information
Table 134. Biosynth Description and Major Businesses
Table 135. Biosynth Product Models, Descriptions and Specifications
Table 136. Biosynth Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 137. Biosynth Recent Developments
Table 138. Otto Chemie Pvt. Ltd. Corporation Information
Table 139. Otto Chemie Pvt. Ltd. Description and Major Businesses
Table 140. Otto Chemie Pvt. Ltd. Product Models, Descriptions and Specifications
Table 141. Otto Chemie Pvt. Ltd. Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 142. Otto Chemie Pvt. Ltd. Recent Developments
Table 143. Pharmaffiliates Analytics and Synthetics P. Ltd. Corporation Information
Table 144. Pharmaffiliates Analytics and Synthetics P. Ltd. Description and Major Businesses
Table 145. Pharmaffiliates Analytics and Synthetics P. Ltd. Product Models, Descriptions and Specifications
Table 146. Pharmaffiliates Analytics and Synthetics P. Ltd. Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 147. Pharmaffiliates Analytics and Synthetics P. Ltd. Recent Developments
Table 148. Clearsynth Labs Corporation Information
Table 149. Clearsynth Labs Description and Major Businesses
Table 150. Clearsynth Labs Product Models, Descriptions and Specifications
Table 151. Clearsynth Labs Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 152. Clearsynth Labs Recent Developments
Table 153. Key Raw Materials Distribution
Table 154. Raw Materials Key Suppliers
Table 155. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 156. Milestones in Production Technology Evolution
Table 157. Distributors List
Table 158. Market Trends and Market Evolution
Table 159. Market Drivers and Opportunities
Table 160. Market Challenges, Risks, and Restraints
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
List of Figures
Figure 1. Melatonin API Product Picture
Figure 2. Global Melatonin API Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Natural Product Picture
Figure 4. Synthetic Product Picture
Figure 5. Global Melatonin API Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Biotechnology Company
Figure 7. Pharmaceutical Company
Figure 8. Others
Figure 9. Melatonin API Report Years Considered
Figure 10. Global Melatonin API Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Melatonin API Revenue (2020-2031) & (US$ Million)
Figure 12. Global Melatonin API Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global Melatonin API Revenue Market Share by Region (2020-2031)
Figure 14. Global Melatonin API Sales (2020-2031) & (Tons)
Figure 15. Global Melatonin API Sales (CAGR) by Region (2020-2031) (Tons)
Figure 16. Global Melatonin API Sales Market Share by Region (2020-2031)
Figure 17. Global Melatonin API Capacity, Production and Utilization (2020-2031) & (Tons)
Figure 18. Global Melatonin API Production Trend by Region (2020-2031) (Tons)
Figure 19. Global Melatonin API Production Market Share by Region (2020-2031)
Figure 20. Production Capacity Enablers & Constraints
Figure 21. Melatonin API Production Growth Rate in North America (2020-2031) & (Tons)
Figure 22. Melatonin API Production Growth Rate in Europe (2020-2031) & (Tons)
Figure 23. Melatonin API Production Growth Rate in China (2020-2031) & (Tons)
Figure 24. Melatonin API Production Growth Rate in Japan (2020-2031) & (Tons)
Figure 25. Top 5 and Top 10 Manufacturers Melatonin API Sales Volume Market Share in 2024
Figure 26. Global Melatonin API Revenue Market Share Ranking (2024)
Figure 27. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 28. Natural Revenue Market Share by Manufacturer in 2024
Figure 29. Synthetic Revenue Market Share by Manufacturer in 2024
Figure 30. Type Eight Revenue Market Share by Manufacturer in 2024
Figure 31. Type Nine Revenue Market Share by Manufacturer in 2024
Figure 32. Global Melatonin API Sales Market Share by Type (2020-2031)
Figure 33. Global Melatonin API Revenue Market Share by Type (2020-2031)
Figure 34. Global Melatonin API Sales Market Share by Application (2020-2031)
Figure 35. Global Melatonin API Revenue Market Share by Application (2020-2031)
Figure 36. North America Melatonin API Sales YoY (2020-2031) & (Tons)
Figure 37. North America Melatonin API Revenue YoY (2020-2031) & (US$ Million)
Figure 38. North America Top 5 Manufacturers Melatonin API Sales Revenue (US$ Million) in 2024
Figure 39. North America Melatonin API Sales Volume (Tons) by Type (2020- 2031)
Figure 40. North America Melatonin API Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 41. North America Melatonin API Sales Volume (Tons) by Application (2020-2031)
Figure 42. North America Melatonin API Sales Revenue (US$ Million) by Application (2020-2031)
Figure 43. US Melatonin API Revenue (2020-2031) & (US$ Million)
Figure 44. Canada Melatonin API Revenue (2020-2031) & (US$ Million)
Figure 45. Mexico Melatonin API Revenue (2020-2031) & (US$ Million)
Figure 46. Europe Melatonin API Sales YoY (2020-2031) & (Tons)
Figure 47. Europe Melatonin API Revenue YoY (2020-2031) & (US$ Million)
Figure 48. Europe Top 5 Manufacturers Melatonin API Sales Revenue (US$ Million) in 2024
Figure 49. Europe Melatonin API Sales Volume (Tons) by Type (2020-2031)
Figure 50. Europe Melatonin API Sales Revenue (US$ Million) by Type (2020-2031)
Figure 51. Europe Melatonin API Sales Volume (Tons) by Application (2020-2031)
Figure 52. Europe Melatonin API Sales Revenue (US$ Million) by Application (2020-2031)
Figure 53. Germany Melatonin API Revenue (2020-2031) & (US$ Million)
Figure 54. France Melatonin API Revenue (2020-2031) & (US$ Million)
Figure 55. U.K. Melatonin API Revenue (2020-2031) & (US$ Million)
Figure 56. Italy Melatonin API Revenue (2020-2031) & (US$ Million)
Figure 57. Russia Melatonin API Revenue (2020-2031) & (US$ Million)
Figure 58. Asia-Pacific Melatonin API Sales YoY (2020-2031) & (Tons)
Figure 59. Asia-Pacific Melatonin API Revenue YoY (2020-2031) & (US$ Million)
Figure 60. Asia-Pacific Top 8 Manufacturers Melatonin API Sales Revenue (US$ Million) in 2024
Figure 61. Asia-Pacific Melatonin API Sales Volume (Tons) by Type (2020- 2031)
Figure 62. Asia-Pacific Melatonin API Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 63. Asia-Pacific Melatonin API Sales Volume (Tons) by Application (2020-2031)
Figure 64. Asia-Pacific Melatonin API Sales Revenue (US$ Million) by Application (2020-2031)
Figure 65. Indonesia Melatonin API Revenue (2020-2031) & (US$ Million)
Figure 66. Japan Melatonin API Revenue (2020-2031) & (US$ Million)
Figure 67. South Korea Melatonin API Revenue (2020-2031) & (US$ Million)
Figure 68. China Taiwan Melatonin API Revenue (2020-2031) & (US$ Million)
Figure 69. India Melatonin API Revenue (2020-2031) & (US$ Million)
Figure 70. Central and South America Melatonin API Sales YoY (2020-2031) & (Tons)
Figure 71. Central and South America Melatonin API Revenue YoY (2020-2031) & (US$ Million)
Figure 72. Central and South America Top 5 Manufacturers Melatonin API Sales Revenue (US$ Million) in 2024
Figure 73. Central and South America Melatonin API Sales Volume (Tons) by Type (2021-2031)
Figure 74. Central and South America Melatonin API Sales Revenue (US$ Million) by Type (2020-2031)
Figure 75. Central and South America Melatonin API Sales Volume (Tons) by Application (2020-2031)
Figure 76. Central and South America Melatonin API Sales Revenue (US$ Million) by Application (2020-2031)
Figure 77. Brazil Melatonin API Revenue (2020-2025) & (US$ Million)
Figure 78. Argentina Melatonin API Revenue (2020-2025) & (US$ Million)
Figure 79. Middle East, and Africa Melatonin API Sales YoY (2020-2031) & (Tons)
Figure 80. Middle East and Africa Melatonin API Revenue YoY (2020-2031) & (US$ Million)
Figure 81. Middle East and Africa Top 5 Manufacturers Melatonin API Sales Revenue (US$ Million) in 2024
Figure 82. Middle East and Africa Melatonin API Sales Volume (Tons) by Type (2021-2031)
Figure 83. South America Melatonin API Sales Revenue (US$ Million) by Type (2020-2031)
Figure 84. Middle East and Africa Melatonin API Sales Volume (Tons) by Application (2020-2031)
Figure 85. Middle East and Africa Melatonin API Sales Revenue (US$ Million) by Application (2020-2031)
Figure 86. GCC Countries Melatonin API Revenue (2020-2025) & (US$ Million)
Figure 87. Turkey Melatonin API Revenue (2020-2025) & (US$ Million)
Figure 88. Egypt Melatonin API Revenue (2020-2025) & (US$ Million)
Figure 89. South Africa Melatonin API Revenue (2020-2025) & (US$ Million)
Figure 90. Melatonin API Industry Chain Mapping
Figure 91. Regional Melatonin API Manufacturing Base Distribution (%)
Figure 92. Melatonin API Production Process
Figure 93. Regional Melatonin API Production Cost Structure
Figure 94. Channels of Distribution (Direct Vs Distribution)
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What is the annual compound growth rate of the global Melatonin API market size from 2025 to 2031?
The annual compound growth rate of the global Melatonin API market is 8.2% 2025 to 2031.
What was the global market size of Melatonin API in 2031?
Which region is expected to have the highest market share?
Which companies rank high in the global Melatonin API market?
What was the global market size of Melatonin API in 2025?
Related Reports
Melatonin API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Melatonin API was estimated to be worth US$ 114 million in 2025 and is projected to reach US$ 196 million, growing at a CAGR of 8.2% from 2026 to 2032.
Published Date: 2026-02-01
Pages: 147
USD 3950.00
(Single User License)
Global Melatonin API Market Research Report 2026
The global Melatonin API market was valued at US$ 114 million in 2025 and is anticipated to reach US$ 196 million by 2032, at a CAGR of 8.2% from 2026 to 2032.
Published Date: 2026-02-01
Pages: 150
USD 2900.00
(Single User License)
Melatonin API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Melatonin API was estimated to be worth US$ 106 million in 2024 and is forecast to a readjusted size of US$ 182 million by 2031 with a CAGR of 8.2% during the forecast period 2025-2031.
Published Date: 2025-02-14
Pages: 135
USD 3950.00
(Single User License)
Global Melatonin API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Melatonin API market size was US$ 106 million in 2024 and is forecast to a readjusted size of US$ 182 million by 2031 with a CAGR of 8.2% during the forecast period 2025-2031.
Published Date: 2025-02-14
Pages: 107
USD 4250.00
(Single User License)
Global Melatonin API Market Research Report 2025
The global market for Melatonin API was valued at US$ 106 million in the year 2024 and is projected to reach a revised size of US$ 182 million by 2031, growing at a CAGR of 8.2% during the forecast period.
Published Date: 2025-02-14
Pages: 112
USD 2900.00
(Single User License)
Global Melatonin API Market Insights, Forecast to 2030
The term "API" in the context of pharmaceuticals stands for Active Pharmaceutical Ingredient. An Active Pharmaceutical Ingredient is the biologically active component of a drug, and it is responsible for its therapeutic effects. Melatonin is a hormone naturally produced in the pineal gland of the brain, and it plays a crucial role in regulating the sleep-wake cycle. When used in the context of pharmaceuticals, "Melatonin API" refers to the active pharmaceutical ingredient of melatonin that is isolated and used as the primary therapeutic agent in medications.
Published Date: 2024-04-11
Pages: 119
USD 4900.00
(Single User License)
Global Melatonin API Market Research Report 2024
The global Melatonin API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-02-21
Pages: 121
USD 2900.00
(Single User License)
Melatonin API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Melatonin API was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-04
Pages: 139
USD 3950.00
(Single User License)
Melatonin API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Melatonin API was estimated to be worth US$ 114 million in 2025 and is projected to reach US$ 196 million, growing at a CAGR of 8.2% from 2026 to 2032.
Published: 2026-02-01
Pages: 147
USD 3950.00 (Single User License)Global Melatonin API Market Research Report 2026
The global Melatonin API market was valued at US$ 114 million in 2025 and is anticipated to reach US$ 196 million by 2032, at a CAGR of 8.2% from 2026 to 2032.
Published: 2026-02-01
Pages: 150
USD 2900.00 (Single User License)Melatonin API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Melatonin API was estimated to be worth US$ 106 million in 2024 and is forecast to a readjusted size of US$ 182 million by 2031 with a CAGR of 8.2% during the forecast period 2025-2031.
Published: 2025-02-14
Pages: 135
USD 3950.00 (Single User License)Global Melatonin API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Melatonin API market size was US$ 106 million in 2024 and is forecast to a readjusted size of US$ 182 million by 2031 with a CAGR of 8.2% during the forecast period 2025-2031.
Published: 2025-02-14
Pages: 107
USD 4250.00 (Single User License)Global Melatonin API Market Research Report 2025
The global market for Melatonin API was valued at US$ 106 million in the year 2024 and is projected to reach a revised size of US$ 182 million by 2031, growing at a CAGR of 8.2% during the forecast period.
Published: 2025-02-14
Pages: 112
USD 2900.00 (Single User License)Global Melatonin API Market Insights, Forecast to 2030
The term "API" in the context of pharmaceuticals stands for Active Pharmaceutical Ingredient. An Active Pharmaceutical Ingredient is the biologically active component of a drug, and it is responsible for its therapeutic effects. Melatonin is a hormone naturally produced in the pineal gland of the brain, and it plays a crucial role in regulating the sleep-wake cycle. When used in the context of pharmaceuticals, "Melatonin API" refers to the active pharmaceutical ingredient of melatonin that is isolated and used as the primary therapeutic agent in medications.
Published: 2024-04-11
Pages: 119
USD 4900.00 (Single User License)Global Melatonin API Market Research Report 2024
The global Melatonin API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-02-21
Pages: 121
USD 2900.00 (Single User License)Melatonin API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Melatonin API was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-04
Pages: 139
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now